Pay in 4 interest-free payments of $5.98 Learn more
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
Increasing your dose re-engages the GLP-1 receptor more fully and restores the weight-loss signals your brain and metabolism rely on
GLP-1 Drug Semaglutide (Ozempic, Wegovy) Reduced Heavy Drinking & Craving in Adults with Alcohol Use Disorder A preliminary, phase 2 clinical trial has shown the potential benefit of a class of popular medications so far approved for control of diabetes and obesity to help reduce alcohol consumption and craving in individuals with alcohol use disorder (AUD)
Semaglutide is a prescription-only medicine licensed for weight loss and type 2 diabetes in the UK
In contrast, the occipital cortex and temporal pole showed increased activation (Binda et al., 2019)
US$ 23.63
US$ 25.38
US$ 21.44
